PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions

Aldeyra Therapeutics, Inc. (ALDX)

Equity · Currency in USD · Last updated Dec 7, 2023
SummaryFinancials

Company Info

ISINUS01438T1060
CUSIP01438T106
SectorHealthcare
IndustryBiotechnology

Highlights

Market Cap$3.51B
EPS$4.31
PE Ratio14.17
PEG Ratio2.31
Revenue (TTM)$1.90B
Gross Profit (TTM)$446.80M
EBITDA (TTM)$430.00M
Year Range$48.67 - $64.36
Target Price$58.17
Short %2.27%
Short Ratio3.14

Share Price Chart


Loading data...

Performance

The chart shows the growth of an initial investment of $10,000 in Aldeyra Therapeutics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-72.56%
6.60%
ALDX (Aldeyra Therapeutics, Inc.)
Benchmark (^GSPC)

S&P 500

Compare to other instruments

Search for stocks, ETFs, and funds to compare with ALDX

Aldeyra Therapeutics, Inc.

Popular comparisons: ALDX vs. SCHD

Return

Aldeyra Therapeutics, Inc. had a return of -54.74% year-to-date (YTD) and -49.19% in the last 12 months.


PeriodReturnBenchmark
Year-To-Date-54.74%18.49%
1 month40.00%4.20%
6 months-72.56%6.60%
1 year-49.19%15.43%
5 years (annualized)-19.39%11.59%
10 years (annualized)N/A9.70%

Monthly Returns Heatmap


JanFebMarAprMayJunJulAugSepOctNovDec
2023-0.42%-11.59%-3.28%-8.07%-10.46%-74.40%61.99%

Risk-Adjusted Performance

This table presents a comparison of risk-adjusted performance metrics for Aldeyra Therapeutics, Inc. (ALDX) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ALDX
Aldeyra Therapeutics, Inc.
-0.46
^GSPC
S&P 500
1.00

Sharpe Ratio

The current Aldeyra Therapeutics, Inc. Sharpe ratio is -0.46. A negative Sharpe ratio means that the risk-free rate is higher than the portfolio's return. This value does not convey any meaningful information.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.00JulyAugustSeptemberOctoberNovemberDecember
-0.46
1.00
ALDX (Aldeyra Therapeutics, Inc.)
Benchmark (^GSPC)

Dividend History


Aldeyra Therapeutics, Inc. doesn't pay dividends

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%JulyAugustSeptemberOctoberNovemberDecember
-78.79%
-5.15%
ALDX (Aldeyra Therapeutics, Inc.)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Aldeyra Therapeutics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Aldeyra Therapeutics, Inc. was 90.10%, occurring on Oct 27, 2023. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-90.1%Apr 28, 2021631Oct 27, 2023
-88.71%Sep 28, 2018367Mar 16, 2020232Feb 16, 2021599
-70.91%Feb 2, 2015267Feb 24, 2016652Sep 26, 2018919
-56.32%Jun 20, 201431Aug 5, 201454Oct 21, 201485
-31.86%Oct 30, 201439Dec 26, 201414Jan 16, 201553

Volatility Chart

The current Aldeyra Therapeutics, Inc. volatility is 29.44%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%120.00%JulyAugustSeptemberOctoberNovemberDecember
29.44%
2.92%
ALDX (Aldeyra Therapeutics, Inc.)
Benchmark (^GSPC)